PQRS Measure
#67Myelodysplastic Syndrome (MDS) and Acute Leukemias: Baseline Cytogenetic Testing Performed on Bone Marrow
The following codes apply for this PQRS measure:
CPT Codes | |||
Code | Modifier | POS | Description |
---|---|---|---|
3155F | Cytogenetic testing performed on bone marrow at time of diagnosis or prior to initiating treatment (HEM) | ||
3155F | 8P | Cytogenetic testing performed on bone marrow at time of diagnosis or prior to initiating treatment (HEM) | |
3155F | 1P | Cytogenetic testing performed on bone marrow at time of diagnosis or prior to initiating treatment (HEM) | |
3155F | 2P | Cytogenetic testing performed on bone marrow at time of diagnosis or prior to initiating treatment (HEM) | |
3155F | 3P | Cytogenetic testing performed on bone marrow at time of diagnosis or prior to initiating treatment (HEM) | |
99201 | Office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: A problem focused history; A problem focused examination; Straightforward medical decision making. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are self limited or minor. Typically, 10 minutes are spent face-to-face with the patient and/or family. | ||
99202 | Office or other outpatient visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination and straightforward medical decision making. When using time for code selection, 15-29 minutes of total time is spent on the date of the encounter. | ||
99203 | Office or other outpatient visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination and low level of medical decision making. When using time for code selection, 30-44 minutes of total time is spent on the date of the encounter. | ||
99204 | Office or other outpatient visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination and moderate level of medical decision making. When using time for code selection, 45-59 minutes of total time is spent on the date of the encounter. | ||
99205 | Office or other outpatient visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination and high level of medical decision making. When using time for code selection, 60-74 minutes of total time is spent on the date of the encounter. | ||
99212 | Office or other outpatient visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination and straightforward medical decision making. When using time for code selection, 10-19 minutes of total time is spent on the date of the encounter. | ||
99213 | Office or other outpatient visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination and low level of medical decision making. When using time for code selection, 20-29 minutes of total time is spent on the date of the encounter. | ||
99214 | Office or other outpatient visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination and moderate level of medical decision making. When using time for code selection, 30-39 minutes of total time is spent on the date of the encounter. | ||
99215 | Office or other outpatient visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination and high level of medical decision making. When using time for code selection, 40-54 minutes of total time is spent on the date of the encounter. | ||
ICD9 Codes | |||
Code | Modifier | POS | Description |
204.00 | Acute lymphoid leukemia, without mention of having achieved remission | ||
204.02 | Acute lymphoid leukemia, in relapse | ||
205.00 | Acute myeloid leukemia, without mention of having achieved remission | ||
205.02 | Acute myeloid leukemia, in relapse | ||
206.00 | Acute monocytic leukemia, without mention of having achieved remission | ||
206.02 | Acute monocytic leukemia, in relapse | ||
207.00 | Acute erythremia and erythroleukemia, without mention of having achieved remission | ||
207.02 | Acute erythremia and erythroleukemia, in relapse | ||
207.20 | Megakaryocytic leukemia, without mention of having achieved remission | ||
207.22 | Megakaryocytic leukemia, in relapse | ||
208.00 | Acute leukemia of unspecified cell type, without mention of having achieved remission | ||
208.02 | Acute leukemia of unspecified cell type, in relapse | ||
238.72 | Low grade myelodysplastic syndrome lesions | ||
238.73 | High grade myelodysplastic syndrome lesions | ||
238.74 | Myelodysplastic syndrome with 5q deletion | ||
238.75 | Myelodysplastic syndrome, unspecified |
Legend:
ClaimThis measure can be submitted via claim. Use the 'Data Collection' pdf associated with the measure.
GroupThis measure can be submitted through one or more groups. Click on the group name to view the group information.
RegistryThis measure can be submitted through registry.
EHRThis measure can be submitted via Electronic Health Record (EHR).
GPRO IThis measure can be submitted via Group Practice Reporting Option 1.
GPRO IIThis measure can be submitted via Group Practice Reporting Option 2.
More information on these alternative reporting mechanisms is available at:
http://www.cms.gov/PQRS/20_AlternativeReportingMechanisms.asp.
ClaimThis measure can be submitted via claim. Use the 'Data Collection' pdf associated with the measure.
GroupThis measure can be submitted through one or more groups. Click on the group name to view the group information.
RegistryThis measure can be submitted through registry.
EHRThis measure can be submitted via Electronic Health Record (EHR).
GPRO IThis measure can be submitted via Group Practice Reporting Option 1.
GPRO IIThis measure can be submitted via Group Practice Reporting Option 2.
More information on these alternative reporting mechanisms is available at:
http://www.cms.gov/PQRS/20_AlternativeReportingMechanisms.asp.
Thank you for choosing Find-A-Code, please Sign In to remove ads.